Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Huurman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Molecular and Cellular Cardiology|November 5, 2020
Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytesMaike Schuldt, Jamie R Johnston, Huan He, et al.
Frontiers in Cardiovascular Medicine|October 4, 2021
Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic CardiomyopathyNikki van der Velde, Roy Huurman, H Carlijne Hassing, et al.
European Heart Journal. Cardiovascular Imaging|June 7, 2022
Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonanceRoy Huurman, Nikki van der Velde, Arend F L Schinkel, et al.
Magnetic Resonance Imaging|July 6, 2026
Association between CMR-derived pulmonary artery pulse wave velocity and pulmonary risk factors: the multi-ethnic study of atherosclerosis COPD studyRoy Huurman, Eric Xie, Yoshiaki Ohyama, et al.
Echocardiography (Mount Kisco, N.Y.)|August 18, 2022
Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathyRoy Huurman, Daniel J Bowen, Ferit O Mutluer, et al.
Cardiovascular Research|July 2, 2025
Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in preclinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trialBeau Olivier van Driel, Stephan A C Schoonvelde, Sonia Borodzicz-Jazdzyk, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Molecular and Cellular Cardiology|November 5, 2020
Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytesMaike Schuldt, Jamie R Johnston, Huan He, et al.
Frontiers in Cardiovascular Medicine|October 4, 2021
Novel Morphological Features on CMR for the Prediction of Pathogenic Sarcomere Gene Variants in Subjects Without Hypertrophic CardiomyopathyNikki van der Velde, Roy Huurman, H Carlijne Hassing, et al.
European Heart Journal. Cardiovascular Imaging|June 7, 2022
Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonanceRoy Huurman, Nikki van der Velde, Arend F L Schinkel, et al.
Magnetic Resonance Imaging|July 6, 2026
Association between CMR-derived pulmonary artery pulse wave velocity and pulmonary risk factors: the multi-ethnic study of atherosclerosis COPD studyRoy Huurman, Eric Xie, Yoshiaki Ohyama, et al.
Echocardiography (Mount Kisco, N.Y.)|August 18, 2022
Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathyRoy Huurman, Daniel J Bowen, Ferit O Mutluer, et al.
Cardiovascular Research|July 2, 2025
Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in preclinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trialBeau Olivier van Driel, Stephan A C Schoonvelde, Sonia Borodzicz-Jazdzyk, et al.
Nature Genetics|January 26, 2021
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effectRafik Tadros, Catherine Francis, Xiao Xu, et al.
Pageof 2